| NCT ID | NCT05734430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Andreana Holowatyj, PhD, MSCI |
| Condition | Appendix Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2022-11-11 |
| Primary Completion | 2032-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2022-11-11 with a primary completion date of 2032-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
Eligibility Criteria
Inclusion Criteria: GAP Social * Known diagnosis of appendix cancer in the United States * Mentally and physically able to consent and participate in the study GAP Vanderbilt * Known diagnosis of appendix cancer * Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study * Mentally and physically able to consent and participate in the study GAP Parent * Biological parents (mother and/or father) of individuals actively participating in the GAP Study * Residing in the United States * Mentally and physically able to consent and participate in the study Exclusion Criteria: * Women pregnant at the time of consent * Prisoners * Unable to provide informed consent * Unable to read, write, or complete questionnaires in English
Contact & Investigator
Andreana N Holowatyj, PhD, MSCI
PRINCIPAL INVESTIGATOR
Vanderbilt-Ingram Cancer Center
Frequently Asked Questions
Who can join the NCT05734430 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Appendix Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05734430 currently recruiting?
Yes, NCT05734430 is actively recruiting participants. Contact the research team at gapcancerstudy@vumc.org for enrollment information.
Where is the NCT05734430 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT05734430 clinical trial?
NCT05734430 is sponsored by Andreana Holowatyj, PhD, MSCI. The principal investigator is Andreana N Holowatyj, PhD, MSCI at Vanderbilt-Ingram Cancer Center. The trial plans to enroll 700 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.